Relevant to our results, loss of IGFBP7 has been associated with chemo-resistance to cisplatin in human cancer cell lines and lung xenografts, possibly by the extracellular signal-regulated kinase (ERK) mitogen-activated protein kinase (MEK-ERK) pathway regulation [58]. The gene discussed is IGFBP7; the disease is cancer.